Plasma neurofilament heavy chain levels and disease progression in amyotrophic lateral sclerosis: insights from a longitudinal study.
about
Clinical Trial Designs in Amyotrophic Lateral Sclerosis: Does One Design Fit All?Quantifying disease progression in amyotrophic lateral sclerosis.Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis.ALS biomarkers for therapy development: State of the field and future directions.Systemic inflammatory response and neuromuscular involvement in amyotrophic lateral sclerosis.Urinary p75ECD: A prognostic, disease progression, and pharmacodynamic biomarker in ALS.Integrative biomarker discovery in neurodegenerative diseases.Non-neuronal Cells in ALS: Role of Glial, Immune cells and Blood-CNS Barriers.Further development of biomarkers in amyotrophic lateral sclerosis.Fluid-Based Biomarkers for Amyotrophic Lateral Sclerosis.Neurofilaments in blood and CSF for diagnosis and prediction of onset in Creutzfeldt-Jakob disease.Biomarkers in Neurodegenerative Diseases.White Matter Injury after Intracerebral Hemorrhage: Pathophysiology and Therapeutic Strategies.Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis: Neurofilament Light Chain Levels in Definite Subtypes of Disease.Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.CSF neurofilament proteins as diagnostic and prognostic biomarkers for amyotrophic lateral sclerosis.Plasma neurofilament light chain concentration in the inherited peripheral neuropathies.Science is 1% inspiration and 99% biomarkers.The proteome of neurofilament-containing protein aggregates in blood.Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALS
P2860
Q26823418-AF4AA024-A239-440C-8878-9D62F945FE23Q35008605-B2A5E0FB-E210-453C-A6FA-F1A68E0FACE7Q35686186-FD2CF9C2-1DAA-4B35-BDDF-AE71A646FACBQ36479616-028F4A37-C3B2-4144-ADF5-3F172F6FCC86Q36981080-2B778034-E0DA-497F-81BD-F1165E66893BQ37730505-BE4EB68F-4CC6-4DA6-8417-AC074CBA32F3Q38542025-1B45B23C-41B2-4335-8D52-91CCE575BA5EQ38701186-6A435EE1-D5DF-422C-965B-0EE17DF12684Q38856405-58AEFC33-3D84-43BE-9394-3779C5D5524AQ39033841-A185C0DF-6725-4422-A272-66ED4D32F22BQ39120758-70FA0C40-C370-43D0-BB4F-3A399E7D8BE5Q39413097-573E083F-8244-4211-9D6F-0B1A8C53109FQ41549073-407AEB4B-9DEE-47B2-98A0-18F92A454366Q47424783-AA1F58A7-C28C-43DF-9A62-A9451C228A5DQ47587631-4538472E-42BD-4094-A6F5-1FEC049EB2FAQ48265513-BC9D9C2E-620A-4DB8-B34D-0E29246C571CQ50102118-50B76D97-1798-4B90-ABCA-C1FD5B0A3099Q50984144-6898D035-54DA-43A3-88B5-ADE80A704046Q55111742-77ABBD18-3B37-4D07-AF7D-CC85052D8179Q57498761-B96A249F-E5FC-47D9-9326-2973A57E0F17
P2860
Plasma neurofilament heavy chain levels and disease progression in amyotrophic lateral sclerosis: insights from a longitudinal study.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Plasma neurofilament heavy cha ...... hts from a longitudinal study.
@ast
Plasma neurofilament heavy cha ...... hts from a longitudinal study.
@en
type
label
Plasma neurofilament heavy cha ...... hts from a longitudinal study.
@ast
Plasma neurofilament heavy cha ...... hts from a longitudinal study.
@en
prefLabel
Plasma neurofilament heavy cha ...... hts from a longitudinal study.
@ast
Plasma neurofilament heavy cha ...... hts from a longitudinal study.
@en
P2093
P2860
P50
P356
P1476
Plasma neurofilament heavy cha ...... hts from a longitudinal study.
@en
P2093
Andrea Malaspina
Ching-Hua Lu
Corrie Macdonald-Wallis
Jan Clarke
Jens Kuhle
Jo Topping
Katie Sidle
Kezia Allen
Linda Greensmith
P2860
P304
P356
10.1136/JNNP-2014-307672
P407
P577
2014-07-09T00:00:00Z